Adult cancer clinical trials that fail to complete: an epidemic?
暂无分享,去创建一个
Paolo Boffetta | Juan Wisnivesky | Ryan Hendricks | W. Oh | M. Galsky | P. Boffetta | A. Latif | R. McBride | J. Wisnivesky | N. Roper | Kristian D Stensland | Russell B McBride | Asma Latif | Nitin Roper | Simon J Hall | William K Oh | Matthew D Galsky | S. Hall | R. Hendricks | K. Stensland
[1] Harlan M Krumholz,et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis , 2012, BMJ : British Medical Journal.
[2] B. Freidlin,et al. Accrual experience of National Cancer Institute Cooperative Group phase III trials activated from 2000 to 2007. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] D. Dilts,et al. A Sense of Urgency: Evaluating the Link between Clinical Trial Development Time and the Accrual Performance of Cancer Therapy Evaluation Program (NCI-CTEP) Sponsored Studies , 2010, Clinical Cancer Research.
[4] Nicholas C. Ide,et al. The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.
[5] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[6] W. McCaskill-Stevens,et al. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. , 2013, Journal of oncology practice.
[7] Harlan M Krumholz,et al. Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.
[8] H. Burstein. Beaten at the Alamo by the Europeans. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.
[9] M. Begg,et al. Strengthening the Career Development of Clinical Translational Scientist Trainees: A Consensus Statement of the Clinical Translational Science Award (CTSA) Research Education and Career Development Committees , 2012, Clinical and translational science.
[10] Scott D Ramsey,et al. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. , 2010, Journal of the National Cancer Institute.
[11] Kay Dickersin,et al. The evolution of trial registries and their use to assess the clinical trial enterprise. , 2012, JAMA.
[12] Moon S. Chen,et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. DiMasi,et al. The cost of biopharmaceutical R&D: is biotech different? , 2007 .
[14] Robert M Califf,et al. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. , 2012, JAMA.
[15] D. Zarin. Factual Errors about ClinicalTrials.gov and Other Federal Mandates in Special Report by Shuster , 2012, Clinical and translational science.
[16] R. Gray,et al. Achieving Sufficient Accrual to Address the Primary Endpoint in Phase III Clinical Trials from U.S. Cooperative Oncology Groups , 2011, Clinical Cancer Research.
[17] D. Dilts,et al. The Prevalence and Economic Impact of Low-Enrolling Clinical Studies at an Academic Medical Center , 2011, Academic medicine : journal of the Association of American Medical Colleges.
[18] D. Gandara,et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] S. Ramsey,et al. Commentary: practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology. , 2008, The oncologist.
[20] Nicholas C. Ide,et al. Trial Registration at ClinicalTrials.gov between May and October 2005. , 2005, The New England journal of medicine.
[21] G. S. Wunderlich,et al. BOARD ON HEALTH CARE SERVICES , 2013 .
[22] Paul Mathew,et al. Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research. , 2009, Clinical genitourinary cancer.
[23] Amy P Abernethy,et al. Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. , 2013, JAMA internal medicine.
[24] L. Perkins,et al. One Foundation’s Strategy to Accelerate Drug Discovery Through Genomics , 2011, Science Translational Medicine.
[25] P. Bach. Visions of hope in cancer: focus on infrastructure: comment on "characteristics of oncology clinical trials" and "toward accountable cancer care". , 2013, JAMA internal medicine.